HCA

HCA Healthcare
NYSE

Real-time Quotes | Nasdaq Last Sale

136.42
+2.09
+1.56%
After Hours: 136.42 0 0.00% 17:51 10/20 EDT
OPEN
134.33
PREV CLOSE
134.33
HIGH
137.98
LOW
133.71
VOLUME
981.90K
TURNOVER
--
52 WEEK HIGH
151.97
52 WEEK LOW
58.38
MARKET CAP
46.11B
P/E (TTM)
14.07
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Were Hedge Funds Too Early To Cash Out Of HCA Healthcare Inc (HCA)?
While the market driven by short-term sentiment influenced by the accomodative interest rate environment in the US, virus news and stimulus talks, many smart money investors are starting to get cautious towards the current bull run since March and hedging or reducing many of their long positions. Some fund managers are betting on Dow hitting […]
Insider Monkey · 14h ago
Is Now The Time To Look At Buying HCA Healthcare, Inc. (NYSE:HCA)?
HCA Healthcare, Inc. (NYSE:HCA) led the NYSE gainers with a relatively large price hike in the past couple of weeks...
Simply Wall St. · 17h ago
HCA Healthcare, Inc. 3rd Quarter 2020 Earnings Conference Call
HCA Healthcare, Inc. (NYSE: HCA) announces the following Webcast:
Business Wire · 1d ago
HCA Healthcare: Social Responsibility Can't Offset Systemic Risks
Having posted a rebound in revenue growth, HCA plans an early repayment of the federal assistance received in the pandemic.The decision raises the company’s corporate profile and indicates its robust liquidity, but political risks and a relentless pandemic continue to weigh on the sector’s outlook.With no upgrade, HCA’s historic trading multiple, with our optimistic EBITDA forecast, indicates a modest premium.Hardly a ‘Buy’ for short-term gains, the stock, thanks to a solid balance sheet to navigate near-term headwinds, is a ‘Hold’ for the long-term investor.
Seekingalpha · 2d ago
Wall Street’s top analysts are betting on stocks like Apple and Snap this earnings season
TipRanks analyst ranking service pinpoints Wall Street's best-performing stocks, like Snap and Apple
CNBC.com · 2d ago
Seth Klarman Axes Akebia Therapeutics Stake From Portfolio
GuruFocus.com · 10/13 17:47
Bill Nygren Market Commentary - 3Q20
At Oakmark, we are long-term investors. We attempt to identify growing businesses that are managed to benefit their shareholders. We will purchase stock in those businesses only when priced substantially below our estimate of intrinsic value. After purchase, we patiently wait for the gap between stock price and intrinsic value to close.In the Oakmark Fund, we buy large businesses because we view them as less risky than small businesses. Rather than defining “large” based on market capitalization, we define it by business fundamentals: sales, net income or shareholders’ equity (book value).The large-cap universe, which refers to the 250 stocks with the highest market capitalizations, is getting smaller. There were 40 newcomers to the large-cap universe in just the past year and they are much smaller businesses than those that exited.
Seekingalpha · 10/13 06:50
Distillate Capital Partners Q3 2020 Investment Letter
Distillate Capital Partners was formed in 2017 and is based in Chicago, IL. The fund strategies use cash-flow-based measures of value and quality that are designed to avoid accounting distortions that we believe have rendered many traditional metrics less relevant in an increasingly asset-light world.Despite the headwind from extremely concentrated gains among a few of the largest stocks in the market, Distillate’s U.S. FSV strategy’s year-to-date return of 6.20% remains ahead of S&P 500 Index’s return of 5.57% and is nearly 18 percentage points above the Russell 1000 Value ETF’s return of -11.64%.Distillate’s International FSV strategy has continued to outperform the iShares MSCI All Country World Ex US (ACWI-EX) ETF with a year-to-date return of 3.72%, considerably ahead of the -5.27% return for the benchmark.Distillate’s U.S. FSV Strategy, Apple and Microsoft were among the strategy’s largest holdings until valuations became more expensive and each stock was sold.The biggest additions to the portfolio in the rebalance were Alphabet, the parent of Google, and Intel, the chipmaker.
Seekingalpha · 10/12 18:15
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of HCA. Analyze the recent business situations of HCA Healthcare through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 23 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average HCA stock price target is 149.95 with a high estimate of 175.00 and a low estimate of 130.00.
EPS
Institutional Holdings
Institutions: 745
Institutional Holdings: 251.44M
% Owned: 74.38%
Shares Outstanding: 338.03M
TypeInstitutionsShares
Increased
217
17.90M
New
57
2.30M
Decreased
288
15.42M
Sold Out
75
1.88M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Healthcare Facilities & Services
+0.47%
Healthcare Providers & Services
+0.06%
Key Executives
Chairman/Director
Thomas Frist
Chief Executive Officer/Director
Samuel Hazen
Chief Financial Officer/Executive Vice President
William Rutherford
Corporate Executive
Michael Cuffe
Corporate Executive
Jon Foster
Corporate Executive
Charles Hall
Corporate Executive
Arnold Moore
Corporate Executive
Jonathan Perlin
Chief Human Resource Officer/Senior Vice President
Jennifer Berres
Senior Vice President - Finance/Treasurer
J. William Morrow
Senior Vice President/Chief Information Officer
Paul Paslick
Senior Vice President/Chief Compliance Officer
Kathleen Whalen
Senior Vice President/General Counsel
Robert Waterman
Senior Vice President/Controller
Christopher Wyatt
Senior Vice President/Director of Marketing
Deborah Reiner
Senior Vice President
Phillip Billington
Senior Vice President
Jane Englebright
Senior Vice President
Sandra Morgan
Senior Vice President
Joseph Sowell
Senior Vice President
Kathryn Torres
Vice President
Jeff Cohen
Director
William Frist
Independent Director
Meg Crofton
Independent Director
meg Crofton
Independent Director
Robert Dennis
Independent Director
Nancy-Ann DeParle
Independent Director
Charles Holliday
Independent Director
Michael Michelson
Independent Director
Wayne Riley
  • Dividends
  • Splits
  • Insider Activity
Declaration Date
Dividend Per Share
Ex-Div Date
01/28/2020
Dividend USD 0.43
02/28/2020
10/29/2019
Dividend USD 0.4
11/29/2019
07/29/2019
Dividend USD 0.4
08/30/2019
04/30/2019
Dividend USD 0.4
05/31/2019
01/29/2019
Dividend USD 0.4
02/28/2019
10/30/2018
Dividend USD 0.35
11/30/2018
07/25/2018
Dividend USD 0.35
08/31/2018
05/01/2018
Dividend USD 0.35
05/31/2018
01/30/2018
Dividend USD 0.35
02/28/2018
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About HCA
HCA Healthcare, Inc., formerly HCA Holdings, Inc., is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia. As of December 31, 2016, the American Group included 80 hospitals, which were located in Colorado, northern Georgia, Kansas, southern Kentucky, Louisiana, Mississippi, Missouri, Oklahoma, Tennessee and Texas. As of December 31, 2016, the Company operated six hospitals in England. The Company owns, manages or operates hospitals, freestanding surgery centers and freestanding emergency care facilities, walk-in clinics, diagnostic and imaging centers, among others.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of HCA Healthcare Inc stock information, including NYSE:HCA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, HCA stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading HCA stock methods without spending real money on the virtual paper trading platform.